共 249 条
[1]
Collaborators GB(2018)Burden of disease in Brazil, 1990-2016: a systematic subnational analysis for the global burden of disease study 2016 Lancet (London, England) 392 760-775
[2]
Nomura S(2017)Population health and regional variations of disease burden in Japan, 1990-2015: a systematic subnational analysis for the global burden of disease study 2015 Lancet (London, England) 390 1521-1538
[3]
Sakamoto H(2016)Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the global burden of disease study 2013 Lancet 387 251-272
[4]
Glenn S(2010)Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries Eur Heart J 8 943-957
[5]
Tsugawa Y(2010)System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention JAMA 304 763-771
[6]
Abe S(2007)Optimal medical therapy with or without PCI for stable coronary artery disease Current Cardiovascular Risk Reports 1 277-278
[7]
Rahman M(2007)Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The global registry of acute coronary events (GRACE) Heart 93 177-182
[8]
Brown J(2005)Predictive factors of major adverse cardiac events in acute myocardial infarction patients complicated by cardiogenic shock undergoing primary percutaneous coronary intervention Circ J 69 154-158
[9]
Ezoe S(2008)General cardiovascular risk profile for use in primary care: the Framingham heart study Circulation 117 743-2037
[10]
Fitzmaurice C(2000)TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy Circulation 102 2031-641